Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > KKR-Stonepeak raise bid in battle for UK's Assura to $2.3 billion
    Finance

    KKR-Stonepeak raise bid in battle for UK's Assura to $2.3 billion

    Published by Global Banking & Finance Review®

    Posted on June 11, 2025

    2 min read

    Last updated: January 23, 2026

    KKR-Stonepeak raise bid in battle for UK's Assura to $2.3 billion - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:equityvaluationsinvestmenthealthcareprivate equity

    Quick Summary

    KKR and Stonepeak have increased their bid for Assura to $2.3 billion, surpassing a rival offer and marking a significant move in the UK healthcare real estate market.

    KKR-Stonepeak raise bid in battle for UK's Assura to $2.3 billion

    (Reuters) -Private equity firms KKR and Stonepeak Partners raised their offer for Britain's Assura on Wednesday to almost 1.7 billion pounds ($2.3 billion), topping a rival bid with their "best and final" offer for the healthcare real estate investor.

    The 52.1 pence a share offer, including dividends, trumps the 51.7 pence proposed by rival suitor Primary Health Properties last month.

    It represents a more than 39% premium to Assura's closing price on February 13, the day before KKR and Stonepeak's first approach. The stock has soared 32% since then, giving Assura a market capitalization of 1.6 billion pounds as of Tuesday.

    Assura manages over 600 healthcare properties with an investment value exceeding 3 billion pounds, and counts Britain's state-backed National Health Service as a customer.

    It joins a growing list of UK companies being bought out by overseas private equity firms or investment companies, attracted by comparatively cheap valuations.

    The latest all-cash offer "is lower risk than other alternatives" and requires no divestment, KKR Managing Director Andrew Furze said in a statement.

    In April, Assura had backed KKR-Stonepeak's previous cash offer, prompting a higher bid from PHP last month. Some analysts had said PHP's offer was more attractive as it comprised cash and stock, and provided ownership of social healthcare assets via a public limited company listed in the UK.

    PHP did not immediately respond to a request for comment.

    ($1 = 0.7415 pounds)

    (Reporting by Yadarisa Shabong and Shashwat Awasthi in Bengaluru. Editing by Janane Venkatraman and Mark Potter)

    Key Takeaways

    • •KKR and Stonepeak raised their bid for Assura to $2.3 billion.
    • •The offer is a 39% premium over Assura's previous stock price.
    • •Assura manages over 600 healthcare properties in the UK.
    • •The bid surpasses a rival offer from Primary Health Properties.
    • •KKR's offer is all-cash, considered lower risk.

    Frequently Asked Questions about KKR-Stonepeak raise bid in battle for UK's Assura to $2.3 billion

    1What is the new bid amount for Assura by KKR and Stonepeak?

    KKR and Stonepeak Partners raised their offer for Assura to almost 1.7 billion pounds, which is approximately $2.3 billion.

    2How does the new offer compare to the previous bid?

    The new offer of 52.1 pence per share exceeds the rival bid from Primary Health Properties, which was 51.7 pence.

    3What is Assura's market capitalization after the bid?

    Assura's stock has increased by 32% since KKR and Stonepeak's initial approach, giving it a market capitalization exceeding 3 billion pounds.

    4What type of properties does Assura manage?

    Assura manages over 600 healthcare properties and counts Britain's National Health Service as a customer.

    5What did KKR's Managing Director say about the offer?

    KKR Managing Director Andrew Furze stated that the latest all-cash offer is 'lower risk than other alternatives' and requires no divestment.

    More from Finance

    Explore more articles in the Finance category

    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    Image for Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    View All Finance Posts
    Previous Finance PostBoE's Saporta says UK banks should borrow more from its repo facilities
    Next Finance PostEuropean shares slip as markets unfazed by US-China deal